Abatacept is a promising treatment for patients with disseminated morphea profunda: Presentation of two cases

Acta Dermato-Venereologica

Volumn 91, Issue 6, 2011, Pages 686-688

  Stausbøl Grøn, Birgitte ^a   Olesen, Anne B ^a   Deleuran, Bent ^a   Deleuran, Mette S ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Abatacept; Morphea profunda; Mrodnan skin score; Orencia

Indexed keywords

ABATACEPT; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DISSEMINATED MORPHEA PROFUNDA; DRUG WITHDRAWAL; EFFECTOR CELL; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; JOINT CONTRACTURE; MORPHEA; PRIORITY JOURNAL; RARE DISEASE; SCLERODERMA; T LYMPHOCYTE; TH17 CELL; TREATMENT RESPONSE;

ADULT; FEMALE; HUMANS; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; SCLERODERMA, LOCALIZED;

EID: 80054907512     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1136     Document Type: Article

References (8)

1. Burgdorf W, Plewig G, Wolff H and Landthaler M, Braun-Falco's dermatology, 3th edition. Springer, 2009.
2. Deleuran B, Abraham DJ. Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma. Nat Clin Pract Rheumatol 2007; 3: 682-683.
3. Kreuter A, Hyun J, Stücker M, Sommer A, Altmeyer P, Gambichler T. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. JAAD 2006; 54: 440-447.
4. Ong VH, Denton CP. Innovative therapies for systemic sclerosis. Curr Opin Rheumatology 2010; 22: 264-272.
5. Mease P, Genovese MC, Gladstein G, Kivitz AJ, Ritchlin C, Tak PP, et al. Abatacept in the treatment of patients with psoriatic arthritis: results of a double-blind, randomized, placebo-controlled phase 2 trial. Arthritis Rheum 2011; 63: 939-948.
6. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281-1285.
7. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361: 888-898.
8. A study to evaluate the safety and efficacy of abatacept in patients with diffuse systemic sclerosis. Available from: http://clinicaltrials.gov/ct2/show/NCT00442611.